240 related articles for article (PubMed ID: 19082469)
41. Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran.
Kuno T; Hirose Y; Yamada Y; Hata K; Qiang SH; Asano N; Oyama T; Zhi H; Iwasaki T; Kobayashi H; Mori H
Oncol Rep; 2006 Mar; 15(3):533-8. PubMed ID: 16465408
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effects of the aqueous extract of Magnolia officinalis on the responses of human urinary bladder cancer 5637 cells in vitro and mouse urinary bladder tumors induced by N-Butyl-N-(4-hydroxybutyl) nitrosamine in vivo.
Lee SJ; Cho YH; Park K; Kim EJ; Kang BS; Jung KH; Kim CH; Kim WJ; Moon SK
Phytother Res; 2009 Jan; 23(1):20-7. PubMed ID: 19048611
[TBL] [Abstract][Full Text] [Related]
43. Anticancer benefits of early versus late use of rapamycin in a rat model of urothelial carcinoma.
Chang CH; Fu YC; Li JR; Shu KH; Ho HC; Shiu YN; Wu MJ
Transplant Proc; 2014 May; 46(4):1240-2. PubMed ID: 24815170
[TBL] [Abstract][Full Text] [Related]
44. DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma.
Gontijo AM; Marcondes JP; Elias FN; de Oliveira ML; de Lima RO; Salvadori DM; de Camargo JL
Environ Mol Mutagen; 2002; 40(3):190-9. PubMed ID: 12355553
[TBL] [Abstract][Full Text] [Related]
45. [Diagnosis and treatment of oral precancerous lesions].
Sudbø J; Warloe T; Aamdal S; Reith A; Bryne M
Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3066-71. PubMed ID: 11757442
[TBL] [Abstract][Full Text] [Related]
46. Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.
Cina SJ; Lancaster-Weiss KJ; Lecksell K; Epstein JI
Arch Pathol Lab Med; 2001 May; 125(5):646-51. PubMed ID: 11300936
[TBL] [Abstract][Full Text] [Related]
47. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression.
Chakraborty T; Chatterjee A; Rana A; Srivastawa S; Damodaran S; Chatterjee M
Life Sci; 2007 Jul; 81(6):489-99. PubMed ID: 17651763
[TBL] [Abstract][Full Text] [Related]
48. DNA content in malignant salivary gland tumours.
Monteiro LS; Palmeira C; Bento MJ; Lopes C
Oral Dis; 2009 May; 15(4):295-301. PubMed ID: 19320959
[TBL] [Abstract][Full Text] [Related]
49. Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.
Baffa R; Fassan M; Sevignani C; Vecchione A; Ishii H; Giarnieri E; Iozzo RV; Gomella LG; Croce CM
Carcinogenesis; 2008 Apr; 29(4):846-8. PubMed ID: 18192690
[TBL] [Abstract][Full Text] [Related]
50. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ
Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958
[TBL] [Abstract][Full Text] [Related]
51. Detection of non-papillary, non-invasive transitional cell G1 carcinoma as revealed by increased DNA instability and other cancer markers.
Hirose M; Sun A; Okubo T; Noriki S; Imamura Y; Fukuda M
Eur J Histochem; 2005; 49(2):199-209. PubMed ID: 15967748
[TBL] [Abstract][Full Text] [Related]
52. DNA ploidy and proliferative index of cardiac myxoma.
Majumdar N; Ray R; Venugopal P; Chopra P
Indian Heart J; 1998; 50(5):535-8. PubMed ID: 10052280
[TBL] [Abstract][Full Text] [Related]
53. DNA image cytometry of bladder tumours: comparison of washings and tumour imprints from 61 patients.
Seigneurin D; Rambeaud JJ; Bosio C; Louis J
Anal Cell Pathol; 1993 Jan; 5(1):39-48. PubMed ID: 8424900
[TBL] [Abstract][Full Text] [Related]
54. [Flow cytometry in cancer of the bladder].
Chassevent A; Allain YM; Chautard D; Larra F; Lépinard V; Soret JY
Cancer Radiother; 1998 Apr; 2 Suppl 1():12s-15s. PubMed ID: 9749070
[TBL] [Abstract][Full Text] [Related]
55. Comparative cytophotometric analysis of reactive lymphoid hyperplasia and low malignant non-Hodgkin lymphoma.
Ruschenburg I; Peters D; Korabiowska M; Droese M
Anticancer Res; 1998; 18(3A):1613-6. PubMed ID: 9673378
[TBL] [Abstract][Full Text] [Related]
56. Cell proliferation studies in primary synovial chondromatosis.
Davis RI; Foster H; Arthur K; Trewin S; Hamilton PW; Biggart DJ
J Pathol; 1998 Jan; 184(1):18-23. PubMed ID: 9582522
[TBL] [Abstract][Full Text] [Related]
57. [A model of rat's urinary bladder tumor induced by subcutaneous injection of N-butyl-N-(4-hydroxybutyl)-nitrosamine].
Pliss GB; Vlasov NN; Iogannsen MG; Frolov AG
Vopr Onkol; 1998; 44(4):432-5. PubMed ID: 9807207
[TBL] [Abstract][Full Text] [Related]
58. Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
Zupančič D; Ovčak Z; Vidmar G; Romih R
Virchows Arch; 2011 May; 458(5):603-13. PubMed ID: 21301865
[TBL] [Abstract][Full Text] [Related]
59. Comparative analysis of DNA content in polyomavirus-infected urothelial cells, urothelial dysplasia and high grade transitional cell carcinoma.
Wojcik EM; Miller MC; Wright BC; Veltri RW; O'Dowd GJ
Anal Quant Cytol Histol; 1997 Oct; 19(5):430-6. PubMed ID: 9349903
[TBL] [Abstract][Full Text] [Related]
60. DNA ploidy in proliferative verrucous leukoplakia.
Klanrit P; Sperandio M; Brown AL; Shirlaw PJ; Challacombe SJ; Morgan PR; Odell EW
Oral Oncol; 2007 Mar; 43(3):310-6. PubMed ID: 16931117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
